Results 1 to 10 of about 83,550 (250)

Interrelation between systemic inflammation markers, endothelial dysfunction and coronary heart disease clinical course after community-acquired pneumonia

Patologìâ, 2015
Extensive research has established that community acquired pneumonia has negative impact on clinical course on coronary heart disease (CHD), but the pathogenic mechanism was not understood. Aim. To study the pro-inflammatory biomarkers and endothelial
N. S. Mykhailovska , T. O. Kulynych
doaj   +1 more source

Advances in community-acquired pneumonia

Therapeutic Advances in Infectious Disease, 2020
Community-acquired pneumonia is one of the commonest and deadliest of the infectious diseases, yet our understanding of it remains relatively poor. The recently published American Thoracic Society and Infectious Diseases Society of America Community ...
Barbara Jones, Grant Waterer
doaj   +1 more source

Effect of vaccination on morbidity and mortality from community-acquired pneumonia

Acta Biomedica Scientifica
Background. Community-acquired pneumonia remains one of the most common and life-threatening forms of pathology among respiratory diseases.The aim of the study. To identify the features of the epidemiology of communityacquired pneumonia in the conditions
T. A. Bayanova, E. S. Stukova, N. A. Kravchenko   +2 more
doaj   +1 more source

MODERN ANTIBACTERIAL THERAPY IN HOSPITAL-ACQUIRED PNEUMONIA

Медицинский совет, 2017
Hospital-acquired pneumonia terminologically unites all types of pneumonia that arise in hospitalized patients: pneumonia in patients beyond artificial lungs ventilation (hospital pneumonia, medical aid-associated pneumonia) and hospital acquired ...
V. B. Beloborodov, V. A. Sinikin
doaj   +1 more source

Role of hepatocyte-derived fibrinogen-related protein 1 as a serum biomarker in the diagnosis of community-acquired pneumonia and sepsis: A cross-sectional study

Journal of International Medical Research
Objective This study aimed to evaluate the potential of hepatocyte-derived fibrinogen-related protein 1 (HFREP1) as a biomarker for community-acquired pneumonia and community-acquired pneumonia secondary to sepsis.
Guoqing Wang, Liuliang Zhang, Xiaolan Zhu, Kai Qian, Lin Zhu, Boqian Chen, Wanjian Gu, Tao Guo, Shijia Liu   +8 more
doaj   +1 more source

Serotypes and antibiotic susceptibility of isolated from hospitalized patients with community-acquired pneumonia in Italy

SAGE Open Medicine, 2017
Background: Pneumonia remain an important public health problem. The primary objective was to determine the proportion of community-acquired pneumonia that is attributable to Streptococcus pneumoniae infection; secondary objectives were the description ...
Marta Di Pasquale, Stefano Aliberti, Chara Azzari, Maria Moriondo, Francesco Nieddu, Francesco Blasi, Marco Mantero   +6 more
doaj   +1 more source

Pneumonia severity index compared to CURB-65 in predicting the outcome of community acquired pneumonia among patients referred to an Iranian emergency department: a prospective survey

Brazilian Journal of Infectious Diseases, 2013
Objective: To compare the prognostic value of the pneumonia severity index and the severity score for community-acquired pneumonia (CURB-65) in predicting mortality and the need for ICU admission of patients with community-acquired pneumonia referred to ...
Mostafa Alavi-Moghaddam, Hooman Bakhshi, Bareza Rezaei, Patricia Khashayar   +3 more
doaj   +1 more source

Antibiotic Resistance of Pseudomonas aeruginosa in Pneumonia at a Single University Hospital Center in Germany over a 10-Year Period. [PDF]

PLoS ONE, 2015
Pseudomonas aeruginosa is a common cause of community-acquired and nosocomial-acquired pneumonia. The development of resistance of P. aeruginosa to antibiotics is increasing globally due to the overuse of antibiotics.
Josef Yayan, Beniam Ghebremedhin, Kurt Rasche   +2 more
doaj   +1 more source

Antibiotics for community-acquired pneumonia [PDF]

Journal of Antimicrobial Chemotherapy, 2009
Antibiotic guidelines for community-acquired pneumonia (CAP) often recommend broad-spectrum agents for severe pneumonia. While these may be entirely appropriate in terms of their spectrum of activity and efficacy, there is a risk that such recommendations could result in over-prescribing of broad-spectrum agents with consequent 'collateral damage ...
Matthew, Dryden, Kieran, Hand, Peter, Davey   +2 more
openaire   +2 more sources

Pneumonia acquired in the Community

Medisur, 2007
A bibliographical revision of the main aspects in the diagnosis and treatment of the patients suffering from pneumonia acquired in the community is carried out.
María Caridad Fragoso Marchante, Iris González Morales, Dianelis Sierra Martínez   +2 more
doaj   +2 more sources